Bleomycin Pulmonary Toxicity in Adult Saudi Patients with Hodgkin's Lymphoma

被引:0
|
作者
Al-Mansour, Mubarak M. [1 ]
Al-Jizani, Wafa A. [1 ]
Al-Fayea, Turki [1 ]
Ruaa, Shafi [1 ]
Kazkaz, Ghieth A. [2 ]
Bayer, Ali M. [2 ]
AL-Foheidi, Meteb [1 ]
Ibrahim, Ezzeldin M. [2 ]
机构
[1] King Abdulaziz Med Ciity, Princess Norah Oncol Ctr, Jeddah, Saudi Arabia
[2] Int Med Ctr, Oncol Ctr Excellence, Jeddah, Saudi Arabia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [11] Radiation Pneumonitis Risk after Bleomycin Toxicity in Hodgkin Lymphoma Patients
    Abou Yehia, Zeinab A.
    Mikhaeel, George
    Smith, Grace
    Pinnix, Chelsea C.
    Milgrom, Sarah A.
    Fanale, Michelle A.
    Reddy, Jay
    Osborne, Eleanor
    Akhtari, Mani
    Gunther, Jillian
    Allen, Pamela
    Dabaja, Bouthaina S.
    BLOOD, 2015, 126 (23)
  • [12] Respiratory Characteristics of Pulmonary Toxicity and Pneumocystis Pneumonia Associated with Bleomycin Use for Hodgkin Lymphoma
    Wieruszewski, P. M.
    Barreto, J. N.
    Thompson, C. A.
    Pawlenty, A. G.
    Potter, A. L.
    Tosh, P. K.
    Mara, K. C.
    Limper, A. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [13] Advancing age and the risk of bleomycin pulmonary toxicity in a largely older cohort of patients with newly diagnosed Hodgkin Lymphoma
    Thomas, Theodore S.
    Luo, Suhong
    Reagan, Patrick M.
    Keller, Jesse W.
    Sanfilippo, Kristen M.
    Carson, Kenneth R.
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (01) : 69 - 74
  • [14] Severe bleomycin induced pneumonitis in patients with Hodgkin's lymphoma
    Markova, J.
    Klaskova, K.
    Vydra, J.
    Polivka, J.
    Zikavska, L.
    Cap, E.
    Vlachova, A.
    Vernerova, Z.
    Sturma, J.
    Kozak, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 55 - 55
  • [15] Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice Paper
    Barrett, Aisling
    Shah, Nimish
    Chadwick, Andrew
    Burns, David
    Burton, Cathy
    Cutter, David J.
    Follows, George A.
    McKay, Pam
    Osborne, Wendy
    Phillips, Elizabeth
    Wilson, Matthew R.
    Collins, Graham P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [16] Bleomycin pulmonary toxicity does impact on Hodgkin's disease outcome.
    Martin, WG
    Ristow, KM
    Colgan, JP
    Habermann, TM
    Ansell, SM
    BLOOD, 2004, 104 (11) : 371A - 371A
  • [17] Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced stage Hodgkin's lymphoma treated with the BAGCOPP regimen:: a report by the German Hodgkin's Lymphoma Study Group
    Eich, H. T.
    Macann, A.
    Bredenfeld, H.
    Hansemann, K.
    Skripnitchenko, R.
    Engert, A.
    Mueller, R.-P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 129 - 129
  • [18] Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced stage Hodgkin's lymphoma treated with the BAGCOPP regimen:: A report by the German Hodgkin's lymphoma study group
    Eich, H. T.
    Macann, A.
    Bredenfeld, H.
    Skripnitchenko, R.
    Zimmermann, C.
    Diehl, V.
    Engert, A.
    Mueller, R.-P.
    ONKOLOGIE, 2008, 31 : 175 - 175
  • [19] Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin's lymphoma treated with the BAGCOPP regimen:: A report by the German Hodgkin's lymphoma study group
    Macann, Andrew
    Bredenfeld, Henning
    Mueller, Rolf-Peter
    Diehl, Volker
    Engert, Andreas
    Eich, Hans Theodor
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (01): : 161 - 165
  • [20] Uncommon manifestation of bleomycin-induced pulmonary toxicity in a patient with Hodgkin's disease
    Garipidou, V
    Vakalopoulou, S
    Zafiriadou, E
    Tziomalos, K
    Perifanis, V
    ANNALS OF ONCOLOGY, 2005, 16 (03) : 514 - 515